Basal cell carcinoma’s low immunogenicity linked to suppression of antigen presentation from its cell of origin

by

Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune-based therapies). Despite harboring the highest tumor mutational burden of all cancers, basal cell carcinomas (BCCs) have low immunogenicity.

Leave A Comment

Your email address will not be published. Required fields are marked *